Collectively, these findings suggest that METTL3 controls the immunosuppressive tumour microenvironment in HPV‐induced CC, highlighting METTL3 as a potential therapeutic target for anti‐cancer immunotherapy. The gene discussed is METTL3; the disease is cancer.